GlassScriptPhysician profile
Eric Jerome Gustafson
NPI 1316470255
$19,518.70
in general payments reported to CMS, 2019-2025
35 companies · $2,885 in 2025
The $2,885 reported for 2025 was more than what 89% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,497 · 2022: $2,845 · 2023: $3,782 · 2024: $2,510 · 2025: $2,885.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,813 · Travel and Lodging: $2,364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,812.82 |
| Travel and Lodging | $2,364.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,180.47 | 2021-2025 | Augment Injectable, Allofiber, Variax |
| Alpha Orthopedic Systems | $3,620.57 | 2021-2023 | |
| Medline Industries LP | $3,099.44 | 2021-2024 | Remedy Essentials, Medline Industries, INC. |
| Smith+Nephew, INC. | $1,589.88 | 2021-2025 | Stravix, Grafix, Grafix Pl |
| Blue Surgical LLC | $626.76 | 2024 | |
| Organogenesis INC. | $336.02 | 2022-2025 | Puraply, Apligraf, Via Matrix |
| Kerecis Limited | $249.00 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Abbott Laboratories | $240.46 | 2025 | Esprit |
| Paragon 28, INC. | $213.30 | 2021-2024 | Ankle Fracture |
| Mimedx Group, INC. | $204.83 | 2024-2025 | |
| Abbvie INC. | $199.95 | 2023-2025 | |
| Bioventus LLC | $194.95 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Sanara Medtech INC. | $186.97 | 2022-2023 | Celleraterx |
| Treace Medical Concepts, INC. | $182.48 | 2022 | |
| Nevro Corp. | $178.69 | 2023-2024 | Senza |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $152.31 | 2023-2024 | Novosorb Btm |
| Integra Lifesciences Corporation | $151.15 | 2022 | |
| Biotissue Holdings INC. | $137.83 | 2023 | |
| Avita Medical Americas, LLC | $131.90 | 2024 | |
| Depuy Synthes Sales INC. | $106.49 | 2021-2025 | Na, Motoband Cp |
| Ani Pharmaceuticals, INC. | $68.95 | 2025 | Purified Cortrophin Gel |
| Acera Surgical, INC. | $68.23 | 2022-2023 | Restrata Wound Matrix |
| Reapplix INC. | $57.23 | 2025 | 3c Patch Kit - Box |
| Ermi LLC | $53.39 | 2023 | |
| Paratek Pharmaceuticals, INC. | $53.03 | 2022-2024 | Nuzyra |
| Kowa Pharmaceuticals America, INC. | $39.53 | 2023 | Seglentis |
| Bone Support INC. | $35.56 | 2022 | |
| Boston Scientific Corporation | $30.57 | 2024 | |
| Next Science LLC | $29.18 | 2024 | Surgx, Blastx, Xperience |
| Ethicon US, LLC | $22.73 | 2025 | Ethicon |
| Amgen INC. | $19.78 | 2025 | Krystexxa |
| Medartis INC. | $17.14 | 2022 | |
| Reprise Biomedical, INC. | $16.16 | 2025 | Miro 3d, Miro3d |
| Kci USA, INC. | $12.87 | 2021 | |
| Orthofix Medical, INC. | $10.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Gustafson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.